First Industry-Sponsored Clinical Trial of a Treatment for Idiopathic Hypersomnia and Narcolepsy without cataplexy

First Industry-Sponsored Clinical Trial of a Treatment for Idiopathic Hypersomnia and Narcolepsy without cataplexy

NeuroTrials, Inc., has begun recruiting people to take part in the testing of a new treatment for idiopathic hypersomnia and narcolepsy without cataplexy. This small phase 1 study will test the safety and efficacy of a drug that is taken by mouth and swallowed. The study will also determine effective doses of the medication to treat these conditions. The researchers are looking for people who

  • Are 18-65 years old
  • Have idiopathic hypersomnia or narcolepsy without cataplexy
  • Are in general good health with no other sleep disorders

All study-related care and study drug will be provided at no cost. Qualified people may receive compensation. If you are interested in finding out more about this study, please visit the NeuroTrials website http://neurotrials.weebly.com/idiopathic-hypersomnia or https://www.facebook.com/arisestudy.



Get SomnusNooze, our e-newsletter

Sign up to receive HF updates, news from the world of sleep research, first-person stories, and more.

You will receive and email from (please check your junk/spam folder if needed) to confirm your subscription to our newsletter through MailChimp. You are not subscribed until you confirm. Thank you for your interest in Hypersomnia Foundation!